Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWdAPM-1 is a peptidomimetic antibiotic agent.1 dAPM-1 forms self-aggregates in the presence of dsDNA with a critical aggregation concentration (CAC) of 8 µg/ml. It selectively induces intracellular aggregation in B. subtilis over HEK293T cells at 128 µg/ml. It is active against S. aureus, methicillin-resistant S. aureus (MRSA), B. subtilis, E. faecium, and M. smegmatis (MICs = 8, 4, 4, 8, and 16 µg/ml, respectively) and is not cytotoxic to NIH3T3 or HK-2 cells (IC50s = >256 µg/ml for both). Extended exposure of S. aureus or E. coli to dAPM-1 for greater than 40 and 30 days, respectively, does not induce resistance to dAPM-1. In vivo, dAPM-1 (10 mg/kg) increases survival in a mouse model of sepsis induced by S. aureus.
WARNING This product is not for human or veterinary use.
1. Molecular physiology of membrane guanylyl cyclase receptors. Physiol. Rev. 96(2), 751-804 (2016).